Hanson & Doremus Investment Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-50
Closed 473
2018
Q4
$0 Hold
50
﹤0.01% 467
2018
Q3
$0 Hold
50
﹤0.01% 493
2018
Q2
$0 Hold
50
﹤0.01% 523
2018
Q1
$0 Hold
50
﹤0.01% 515
2017
Q4
$0 Hold
50
﹤0.01% 510
2017
Q3
$0 Hold
50
﹤0.01% 506
2017
Q2
$0 Hold
50
﹤0.01% 502
2017
Q1
$1K Sell
50
-1
-2% -$13 ﹤0.01% 470
2016
Q4
$619 Hold
51
﹤0.01% 452
2016
Q3
$1K Hold
51
﹤0.01% 441
2016
Q2
$1K Hold
51
﹤0.01% 439
2016
Q1
$1K Hold
51
﹤0.01% 454
2015
Q4
$1K Hold
51
﹤0.01% 464
2015
Q3
$1K Hold
51
﹤0.01% 449
2015
Q2
$1K Buy
51
+20
+65% +$1.98K ﹤0.01% 438
2015
Q1
$6K Hold
31
﹤0.01% 412
2014
Q4
$7K Hold
31
﹤0.01% 402
2014
Q3
$8K Buy
31
+15
+94% +$4.07K ﹤0.01% 378
2014
Q2
$5K Buy
+16
New +$5.08K ﹤0.01% 393

Other funds holding APEN

Hanson & Doremus Investment Management's APEN Position: Q1 2019 in Review

Hanson & Doremus Investment Management sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2019, closing a stake of 50 shares.

Hanson & Doremus Investment Management first reported a position in APEN in Q2 2014 and held it in 19 quarters. The position peaked at $8K in Q3 2014. 31 funds tracked by Wall St. Rank hold APEN as of Q1 2019.

  • Hanson & Doremus Investment Management reported no remaining Apollo Endosurgery, Inc. position as of Q1 2019 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 50 Apollo Endosurgery, Inc. shares in Q1 2019.
  • Hanson & Doremus Investment Management first reported a position in Apollo Endosurgery, Inc. in Q2 2014 and held it in 19 quarters.
  • Hanson & Doremus Investment Management's Apollo Endosurgery, Inc. position peaked at $8K in Q3 2014.
  • 31 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2019.

Based on Hanson & Doremus Investment Management's 13F filing for Q1 2019, filed 23 Apr 2019.